![Serge Messerlian](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Serge Messerlian
Directeur Général chez
Creyon Bio, Inc.
Profil
Serge Messerlian is Chief Executive Officer at Creyon Bio, Inc. starting in 2025 and Operating Partner at DCVC Management Co. LLC since 2024.
Former roles include Chief Executive Officer at Janssen Oncology, Inc., Aragon Pharmaceuticals, Inc., and Chief Executive Officer & Director at Teon Therapeutics, Inc. Education includes undergraduate and graduate degrees from McGill University and an MBA from the University of Toronto.
Postes actifs de Serge Messerlian
| Sociétés | Poste | Début |
|---|---|---|
DCVC Management Co. LLC
 DCVC Management Co. LLC Investment ManagersFinance DCVC invests in companies located in the United states and Europe. The firm target companies operating mainly in the deep technology sector. It provides financing for seed, early, and later stage capital requirements. It also participates in subsequent rounds. | Private Equity Investor | 01/01/2024 |
Creyon Bio, Inc.
 Creyon Bio, Inc. BiotechnologyHealth Technology Develops nucleic acid drugs | Directeur Général | 01/08/2024 |
Anciens postes connus de Serge Messerlian
| Sociétés | Poste | Fin |
|---|---|---|
Teon Therapeutics, Inc.
 Teon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovering and developing molecule drugs for cancer immunotherapy, cardiovascular and metabolic diseases | Directeur Général | - |
Aragon Pharmaceuticals, Inc.
 Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Directeur Général | - |
Janssen Oncology, Inc.
 Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer | Directeur Général | - |
Formation de Serge Messerlian
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aragon Pharmaceuticals, Inc.
Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Janssen Oncology, Inc.
Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer | Health Technology |
DCVC Management Co. LLC
DCVC Management Co. LLC Investment ManagersFinance DCVC invests in companies located in the United states and Europe. The firm target companies operating mainly in the deep technology sector. It provides financing for seed, early, and later stage capital requirements. It also participates in subsequent rounds. | Finance |
Teon Therapeutics, Inc.
Teon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovering and developing molecule drugs for cancer immunotherapy, cardiovascular and metabolic diseases | Commercial Services |
Creyon Bio, Inc.
Creyon Bio, Inc. BiotechnologyHealth Technology Develops nucleic acid drugs | Health Technology |
